Lots of good comments on #statins
When to Start a Statin Is a Preference-Sensitive Decision.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2022 – Jul 2024Where it's discussed
-
X / Twitter13 posts
-
Facebook4 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
Discussion participants express general agreement that statin initiation should depend on individual patient preferences, with posts referencing the importance of risk factors and shared decision-making. The tone varies from neutral analysis to active debate, with some participants emphasizing the article's role in shifting clinical approaches, as seen in phrases like 'individualized' and 'preference-sensitive.'
Most participants agree that the decision to start a statin should be individualized and preference-sensitive, indicating overall support for the article's perspective.
The social discussions show high interest, with many posts engaging deeply with topics such as primary prevention, risk factors, and personalized treatment plans.
Several discussions reference specific concepts like ARR, LDL, and treatment duration, demonstrating active engagement and nuanced understanding.
The conversations highlight a recognition of the article's influence on clinical decision-making and policy debates, suggesting a moderate impact on current practices.
Top posts
Most liked on X and Bluesky@pash22 @sfinnikin @DrRaniKhatib I agree that to start a statin for primary prevention is preference sensitive, should be indivlzed (not pop-based) & should use more neutral SDM w/i a certain zone, as the title of the commentary below suggests https://t.co/NvF7JcRNRR
@KevinDr_ver Here's a different take on this. https://t.co/NvF7JczEDJ
When to Start a Statin Is a Preference-Sensitive Decision https://t.co/JCCkLj5tYL via @ProfHayward https://t.co/iD5W9S8W5Q
@pnatarajanmd @MaxJordan_N ARR is what's important, and LDL is only a minor factor in most ppl w/o multiple RFs until age >55. Agree that 4-5yr A1c/DM effects small, BUT unknown if treating 20yrs before ASCVD ARR is substantive. https://t.co/LRGdTOEb3i
@venkmurthy @JeremySussman @minouye271 Here are my thoughts on the issue of earlier Rx given current evidence. https://t.co/NvF7JcRg2j
All mentions
This Week in Cardiology Highlights and Recent Developments
This week's topics include venous closure devices versus sutures after atrial fibrillation ablation, GLP1s linked to blindness and cancer risks, and decision-making in statin initiation. The discussion targets…
Advances in Left Atrial Appendage Occlusion and Elderly Statin Use
This week, Dr. John Mandrola discusses new research on left atrial appendage closure outcomes and the potential benefits of DNA statins in the elderly, highlighting recent studies and their clinical implications for…
When to Start a Statin Is a Preference-Sensitive Decision https://t.co/JCCkLj5tYL via @ProfHayward https://t.co/iD5W9S8W5Q
RT @ProfHayward: @pash22 @sfinnikin @DrRaniKhatib I agree that to start a statin for primary prevention is preference sensitive, should be…
@pash22 @sfinnikin @DrRaniKhatib I agree that to start a statin for primary prevention is preference sensitive, should be indivlzed (not pop-based) & should use more neutral SDM w/i a certain zone, as the title of the commentary below suggests https://t.co/NvF7JcRNRR
@dan_soffer @CBallantyneMD @hmkyale @ASPCardio @nationallipid @virani_md @VCUDPOSChair @khurramn1 2. Examples related to statin use in primary prevention: https://t.co/NvF7JcRNRR
@pnatarajanmd @MaxJordan_N ARR is what's important, and LDL is only a minor factor in most ppl w/o multiple RFs until age >55. Agree that 4-5yr A1c/DM effects small, BUT unknown if treating 20yrs before ASCVD ARR is substantive. https://t.co/LRGdTOEb3i
When to Start a Statin Is a Preference-Sensitive Decision https://t.co/ERTcI4Pom8 via @ProfHayward
@raj_mehta @ThomasAgoritsas @TomPMarshall @dr_dmorgan @pash22 @broomedocs @djc795 @RichardLehman1 @mikejohansenmd @sfinnikin @woodford_henry @alf_collins @drjessicawatson @MiYao43827017 @tanner_caverly @First10EM @EMManchester @DKorenstein @GRADE_WG @bmj_latest This has been reproduced by advocates of a simple age based criterion. https://t.co/NvF7JcRg2j
@KevinDr_ver Here's a different take on this. https://t.co/NvF7JczEDJ
RT @drjohnm: Lots of good comments on #statins
RT @drjohnm: Lots of good comments on #statins
RT @drjohnm: Lots of good comments on #statins
Lots of good comments on #statins
@venkmurthy @JeremySussman @minouye271 Here are my thoughts on the issue of earlier Rx given current evidence. https://t.co/NvF7JcRg2j
JM
RH
AP
CA
JP
AJ